The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas

BACKGROUND: Prolactinoma is a functional pituitary adenoma that secretes excessive prolactin. Dopamine agonists (DAs) such as bromocriptine (BRC) are the first-line treatment for prolactinomas, but the resistance rate is increasing year by year, creating a clinical challenge. Therefore, it is urgent...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuman, Wang, Aihua, Zhang, Yu, Zhu, Kejing, Wang, Xiong, Chen, Yonggang, Wu, Jinhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609849/
https://www.ncbi.nlm.nih.gov/pubmed/34814904
http://dx.doi.org/10.1186/s12902-021-00900-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609849/
https://www.ncbi.nlm.nih.gov/pubmed/34814904
http://dx.doi.org/10.1186/s12902-021-00900-9

Ejemplares similares